CLINICAL_TRIALS
trial_result
· 2013-07-11
Clinical Trial Update: FMS European Long-Term Study [Phase 3]
Summary
A Phase 3 European long-term study for fibromyalgia sponsored by Pierre Fabre Medicament has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pierre Fabre Medicament | Conditions: Fibromyalgia Syndrome | Phase 3 | Status: COMPLETED